A retrospective study of salvage surgery for recurrent nasopharyngeal carcinoma
Creators
- 1. Military General Hospital of Beijing, Beijing (China)
- 2. Fuzhou General Hospital, Fuzhou (China)
- 3. Academy of Integrative Medicine, Fujian Univ. of Traditional Chinese Medicine, Fuzhou (China)
Description
Nasopharyngeal carcinoma is sensitive to radiotherapy. When there is local relapse, re-irradiation treatment is inevitably associated with serious complications and decreased quality of life. Surgical resection offers an alternative treatment option with acceptable morbidity. Seventy-one consecutive patients with primary recurrence of nasopharyngeal carcinoma after radiation underwent nasopharyngectomy from January 1, 1990 to June 30, 2006. Follow-up ranged from 12 to 127 months. The actuarial 1-, 2-, 3-, and 5-year survival rates were 88.1, 62.1, 48.9, and 42.1%, respectively. The 1-, 2-, 3-, and 5-year local control rates were 74.6, 61.9, 56.3, and 53.5%, respectively. There was no surgical mortality. The 3-year overall survival rates for recurrent T1, T2, T3, and T4 disease after surgery were 56, 61.1, 30.6, and 0%, respectively; the corresponding 5-year overall survival rates were 49.1, 24.7, 0, and 0%, respectively. Other prognostic factors with a negative effect on survival include lymph node metastasis, invasion of skull base and parapharyngeal space, and positive margin. Advances in skull base surgery make possible the effective control of primary recurrence of nasopharyngeal carcinoma for patients with rT1 and rT2 stages, with acceptable mortality and morbidity. (author)
Additional details
Publishing Information
- Journal Title
- International Journal of Clinical Oncology
- Journal Volume
- 17
- Journal Issue
- 3
- Journal Page Range
- p. 212-217
- ISSN
- 1341-9625
INIS
- Country of Publication
- Japan
- Country of Input or Organization
- Japan
- INIS RN
- 44008892
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- ABSORBED RADIATION DOSES; CARCINOMAS; GY RANGE 10-100; LYMPH NODES; METASTASES; PATIENTS; PHARYNX; RADIOTHERAPY; SURGERY; SURVIVAL CURVES; SURVIVAL TIME
- Descriptors DEC
- ABSORBED DOSE RANGE; BODY; DIGESTIVE SYSTEM; DISEASES; DOSES; GY RANGE; LYMPHATIC SYSTEM; MEDICINE; NEOPLASMS; NUCLEAR MEDICINE; ORGANS; RADIATION DOSE RANGES; RADIATION DOSES; RADIOLOGY; RESPIRATORY SYSTEM; THERAPY